FDA Import Refusal AEK-8555072-9/11/1 — Eli Lilly & Company
The FDA refused shipment AEK-8555072-9/11/1 from Eli Lilly & Company (United States) on Jun 23, 2025. The refused product falls under Drugs and Biologics — EMPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jun 23, 2025
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY73 EMPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75